We are live on ! Find out more
First Quadrant

First Quadrant Portfolio holdings

AUM $18M Turnover 89.22%
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.7 years

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.39%
2 Technology 15.39%
3 Healthcare 14.54%
4 Industrials 13.4%
5 Energy 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NOC icon
51
Northrop Grumman
NOC
$77.1B
$23.9M 0.53%
199,600
-110,800
-36% -$13.4M
2013 Q2
4 quarters
CSCO icon
52
Cisco
CSCO
$383B
$23.5M 0.52%
945,800
+115,400
+14% +$2.75M
2013 Q2
4 quarters
WLK icon
53
Westlake
WLK
$7.63B
$22.5M 0.5%
269,200
– –
2013 Q2
4 quarters
DST
54
DELISTED
DST Systems
DST
$22.4M 0.5%
486,200
-1,066
-0.2% -$49K
2013 Q2
4 quarters
PG icon
55
Procter & Gamble
PG
$395B
$22.4M 0.5%
284,967
+23,598
+9% +$1.9M
2013 Q2
4 quarters
EG icon
56
Everest Group
EG
$15.6B
$22.2M 0.49%
138,425
+21,200
+18% +$3.36M
2013 Q2
4 quarters
ALK icon
57
Alaska Air
ALK
$4.13B
$22.1M 0.49%
464,656
– –
2013 Q2
4 quarters
VLO icon
58
Valero Energy
VLO
$95.9B
$21.9M 0.49%
437,661
+144,717
+49% +$7.98M
2013 Q2
4 quarters
AES icon
59
AES
AES
$10.7B
$21.9M 0.49%
1,408,900
+60,900
+5% +$875K
2013 Q2
4 quarters
TSN icon
60
Tyson Foods
TSN
$22.1B
$21.7M 0.48%
578,630
+18,606
+3% +$745K
2013 Q2
4 quarters
HUM icon
61
Humana
HUM
$46.3B
$21.2M 0.47%
165,627
+130,500
+372% +$15.5M
2013 Q2
4 quarters
WDR
62
DELISTED
Waddell & Reed Financial
WDR
$21M 0.47%
335,900
+119,900
+56% +$7.76M
2013 Q2
4 quarters
BEN icon
63
Franklin Templeton
BEN
$17.7B
$20.8M 0.46%
360,167
-85,100
-19% -$4.66M
2013 Q2
4 quarters
M icon
64
Macy's
M
$6.5B
$20.7M 0.46%
356,100
-137,100
-28% -$7.96M
2013 Q2
4 quarters
LLY icon
65
Eli Lilly
LLY
$1.23T
$20.3M 0.45%
325,800
-242,500
-43% -$14.5M
2013 Q2
4 quarters
PSX icon
66
Phillips 66
PSX
$95.5B
$19.7M 0.44%
244,561
-109,400
-31% -$9.01M
2013 Q2
4 quarters
AEP icon
67
American Electric Power
AEP
$68.9B
$19.6M 0.44%
351,200
+276,000
+367% +$14.6M
2013 Q2
4 quarters
BRCD
68
DELISTED
Brocade Communications Systems
BRCD
$18.9M 0.42%
2,051,700
+204,500
+11% +$1.88M
2013 Q2
4 quarters
RF icon
69
Regions Financial
RF
$23.7B
$18.8M 0.42%
1,772,500
-3,300
-0.2% -$34.4K
2013 Q2
4 quarters
EGN
70
DELISTED
Energen
EGN
$18.7M 0.42%
210,000
+165,900
+376% +$14M
2013 Q2
4 quarters
CELG
71
DELISTED
Celgene
CELG
$18.5M 0.41%
215,600
– –
2013 Q2
4 quarters
BIIB icon
72
Biogen
BIIB
$37.2B
$18.3M 0.41%
58,045
-92,400
-61% -$27.8M
2013 Q2
4 quarters
UTHR icon
73
United Therapeutics
UTHR
$24.6B
$18.3M 0.41%
206,600
-44,200
-18% -$4.25M
2013 Q2
4 quarters
RKT icon
74
DELISTED
Rock-Tenn
RKT
$18.3M 0.41%
346,000
– –
2013 Q2
4 quarters
IBM icon
75
IBM
IBM
$216B
$18.2M 0.4%
104,910
-14,644
-12% -$2.64M
2013 Q2
4 quarters

Similar funds

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited Bally Technologies in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.